The interleukin-6 promoter polymorphism in Gaucher disease: a new modifier gene?

QJM. 2003 Aug;96(8):575-8. doi: 10.1093/qjmed/hcg097.

Abstract

Background: Individuals with Gaucher disease vary significantly with regard to degree of bone disease, but there are no predictive markers for severity of skeletal involvement.

Aim: To determine the frequency of polymorphisms of interleukin-6 (IL-6) among patients with Gaucher disease, and the relationship to bone mineral density (BMD) and other markers of disease severity.

Design: Case-control study.

Methods: Genotyping for the 174G --> C promoter polymorphism of IL-6 was performed in adult patients with Gaucher disease for whom there was concurrent bone mineral density (BMD) data and in healthy Ashkenazi Jewish controls.

Results: The prevalence of allelic variants (58% G/G, 36% G/C, and 6% C/C) was similar in Ashkenazi Jewish adults with Gaucher disease as in Ashkenazi Jewish controls, but significantly different (p < 0.05) from that reported among Caucasians. No statistically significant correlation was found between IL-6 genotypes and BMD or markers of severity of Gaucher disease. Patients with the C/C genotype had relatively mild Gaucher disease.

Discussion: The IL-6 polymorphisms appear to be distributed differently in Ashkenazi Jews than among other Caucasians. In Gaucher disease, the C/C genotype may be associated with a milder Gaucher phenotype, and may serve as a mitigating genetic modifier.

MeSH terms

  • Adolescent
  • Adult
  • Bone Density / genetics
  • Case-Control Studies
  • Female
  • Gaucher Disease / genetics*
  • Genetic Predisposition to Disease / genetics
  • Genotype
  • Humans
  • Interleukin-6 / genetics*
  • Jews / genetics
  • Male
  • Middle Aged
  • Polymorphism, Genetic / genetics*
  • Promoter Regions, Genetic / genetics*
  • Severity of Illness Index

Substances

  • Interleukin-6